Skip to main content
Gut logoLink to Gut
. 1995 Apr;36(4):639–640.

Reply

Gunnar Järnerot
PMCID: PMC1382513

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calder I. C., Funder C. C., Green C. R., Ham K. N., Tange J. D. Nephrotoxic lesions from 5-aminosalicylic Acid. Br Med J. 1972 Jan 15;1(5793):152–154. doi: 10.1136/bmj.1.5793.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Vos M., Verdievel H., Schoonjans R., Praet M., Bogaert M., Barbier F. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations. Gut. 1992 Oct;33(10):1338–1342. doi: 10.1136/gut.33.10.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Rijk M. C., van Schaik A., van Tongeren J. H. Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea. Scand J Gastroenterol. 1992 Oct;27(10):863–868. doi: 10.3109/00365529209000155. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES